» Articles » PMID: 10551422

Interleukin-10 (IL-10) Genotypes in Inflammatory Bowel Disease

Overview
Journal Tissue Antigens
Date 1999 Nov 7
PMID 10551422
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-10 (IL-10) is an anti-inflammatory cytokine. Its production in humans is under genetic control, and genotype defines high or low producers of this cytokine. This study addresses the hypothesis that idiopathic inflammatory bowel disease (IBD) patients are more likely to have the low IL-10 producer genotype and phenotype. DNA was extracted from blood cells of patients with Crohn's disease (CD) or with ulcerative colitis (UC) for IL-10 genotyping. The frequency of the high IL-10 producer allele (-1082*G) was decreased in the whole IBD group (41% vs. 51%, P = 0.03) and in the UC patients compared with normal controls (37% vs. 51%; P = 0.04). Hence, there appears to be an association between the IL-10 genotypes and IBD. This suggests that individuals genetically predisposed to produce less IL-10 are at a higher risk of developing IBD, in particular, UC.

Citing Articles

Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial.

Vazirian F, Samadi S, Abbaspour M, Taleb A, Bagherhosseini H, Mozaffari H Inflammopharmacology. 2022; 30(6):2145-2152.

PMID: 35723850 DOI: 10.1007/s10787-022-00991-3.


Evaluation of periodontal status and cytokine levels in saliva and gingival crevicular fluid of patients with inflammatory bowel diseases.

Enver A, Ozmeric N, Isler S, Toruner M, Fidan C, Demirci G J Periodontol. 2022; 93(11):1649-1660.

PMID: 35665507 PMC: 10083950. DOI: 10.1002/JPER.22-0065.


Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis.

Basso P, Sales-Campos H, Nardini V, Duarte-Silva M, Alves V, Bonfa G Front Immunol. 2021; 12:618365.

PMID: 34434187 PMC: 8382038. DOI: 10.3389/fimmu.2021.618365.


Role of Goblet Cells in Intestinal Barrier and Mucosal Immunity.

Yang S, Yu M J Inflamm Res. 2021; 14:3171-3183.

PMID: 34285541 PMC: 8286120. DOI: 10.2147/JIR.S318327.


Optimizing infrared spectral discrimination to enhance disease diagnostics: monitoring the signatures of inflammatory bowel diseases with anti-TNFα therapy.

Ghimire H, Hu X, Qin G, Perera A Biomed Opt Express. 2020; 11(8):4679-4694.

PMID: 32923071 PMC: 7449716. DOI: 10.1364/BOE.394895.